News from Zyme and the companies we work with.
Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform with Analog Devices
The companies are working together on next-generation technology in the fast-growing field of synthetic biology. This new technology will improve the quality, speed, and cost of developing synthetic biological solutions [...]
CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing
PhysioMimix NASH assay used to provide human-relevant data on compound efficacy for Inipharm’s lead candidate, INI-822 Submission represents first example of an OOC provider’s data supporting clinical progression of a [...]
PlaqueTec recruits first ten patients in BIOPATTERN trial
Trial to investigate atherosclerotic cardiovascular diseases receives MHRA approval to continue recruitment towards 300-patient target Unique PlaqueTec Liquid Biopsy System will be used to collect blood samples containing biomolecules localising [...]
Exonate announces successful completion of Phase Ib/IIa trial in diabetic macular oedema
Lead ophthalmology candidate EXN407 has potential to be the first topical treatment for diabetic retinopathy/diabetic macular oedema EXN407 met all endpoints and displayed encouraging biological activity in diabetic patients with [...]
CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA
Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry Cambridge, UK, 23 November 2023: CN Bio, [...]
OBN (UK) Ltd Shines a Light on Outstanding Companies within the Life Sciences Industry, at the 2023 OBN Awards, 22 November 2023, London
Abingdon, UK, Thursday 23 November: – OBN (UK) Ltd., the not-for-profit membership organisation that catalyses growth for the life sciences industry, is delighted to announce the winners of their 2023 [...]
Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
Experienced quality assurance professional joins team to support ongoing strategic growth plans as the Company expands access and capabilities of INDUCE-seq DNA break mapping platform Expansion to leadership team follows [...]
NanoSyrinx appoints Anthony Johnson as Non-Executive Director
Appointment of Big Pharma executive strengthens leadership team to drive ambitious growth strategy Coventry, UK, 10 November 2023: NanoSyrinx, a synthetic biology company developing a novel platform for targeted intracellular [...]
Lario Therapeutics receives “Company Making a Difference Award” from CDLK5 Forum, recognising its unique approach to precision medicine for genetic epilepsies
“CDLK5 Forum Award for Excellence - Company Making a Difference 2023 Pre-clinical” presented by the Loulou Foundation at the CDKL5 Forum, 6th-7th November in London First-in-class ion channel inhibitors show [...]
Enhanc3D Genomics expands leadership team with the appointment of Hazel Jones as Chief Operating Officer
Key appointment supports company growth and strategic commercial and academic partnerships Cambridge, UK, 06 November 2023: Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for [...]
CN Bio appoints Neil Rumbelow as Director of Product Development
Key senior appointment to drive research and development activities for portfolio of PhysioMimix OOC microphysiological systems Cambridge, UK, 02 November 2023: CN Bio, a leading Organ-on-a-Chip (OOC) company that designs [...]
Optibrium introduces cloud-based version of StarDrop drug discovery platform
Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers Optibrium recently received ISO 27001 accreditation [...]
